久久亚洲国产成人影院-久久亚洲国产的中文-久久亚洲国产高清-久久亚洲国产精品-亚洲图片偷拍自拍-亚洲图色视频

• Search
• HOME
• CHINA
• WORLD
• BUSINESS
• LIFESTYLE
• CULTURE
• TRAVEL
• VIDEO
• SPORTS
• OPINION
• REGIONAL
• FORUM
• NEWSPAPER
• MOBILE

Global EditionASIA 中文雙語Fran?ais

1. Home
2. World
/ Europe

CureVac fails in COVID-19 vaccine trial with 47% efficacy

By Ouyang Xueyan | chinadaily.com.cn | Updated: 2021-06-18 00:04

Share

Share - WeChat

CLOSE

German biotech CureVac's COVID-19 vaccine has come out of a late-stage trial with 47 percent efficacy but the health ministry has said this will not impact the country's vaccination rollout.

Photos

SE Asian businesses face 400 ransomware attacks daily

Extreme heat takes toll on South and Southeast Asia

South-South cooperation vital amid uncertainty

China-Russia relations maintain steady growth

Rehearsal for Victory Day military parade held in Moscow, Russia

UN envoy emphasizes China's role in victory over fascism

Most Viewed in 24 Hours

World in Focus

The galloping 'firefighters'

Across Asia +

SE Asian businesses face 400 ransomware attacks daily

Extreme heat takes toll on South and Southeast Asia

Special Coverage +

7.9-magnitude earthquake hits Myanmar

Russia-Ukraine conflict: Three years on

Friends Afar +

Danish man's green journey across China

Ties That Bind +

Vital pass to boost China-Pakistan trade

English

中文

Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.

License for publishing multimedia online 0108263

Registration Number: 130349

About China Daily

Advertise on Site

Contact Us

Job Offer

Expat Employment

FOLLOW US